Search

Your search keyword '"Waldstreicher, Joanne"' showing total 2 results
Start Over Author "Waldstreicher, Joanne" Database Gale General OneFile
2 results on '"Waldstreicher, Joanne"'

1. Drugs of unproven benefit for COVID-19: a pharma perspective on ethical allocation of available therapies

Author

Caplan, Arthur L., Waldstreicher, Joanne, Childers, Karla, and Maree, Aran

Subjects
Health care rationing -- Methods -- Laws, regulations and rules -- Ethical aspects, COVID-19 -- Drug therapy, Government regulation, Health care industry
Abstract

The current COVID-19 outbreak has led to global efforts to care for those affected, contain the current outbreak, and develop vaccines and therapeutic approaches to prevent and treat COVID-19. In [...]

Published
2020
Full Text
View/download PDF

2. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia

Author

McConnell, John D., Bruskewitz, Reginald, Walsh, Patrick, Andriole, Gerald, Lieber, Michael, Holtgrewe, H. Logan, Albertsen, Peter, Roehrborn, Claus G., Nickel, J. Curtis, Wang, Daniel Z., Taylor, Alice M., and Waldstreicher, Joanne

Subjects
Finasteride -- Evaluation, Prostate -- Hypertrophy, Urine -- Retention
Abstract

Finasteride therapy may reduce the need for prostate surgery and the risk of acute urinary retention in men with enlarged prostate glands. Researchers treated 3,040 men for four years with finasteride or placebo, and monitored urinary symptoms, complications, and the need for surgical treatment. During the study, 10% of men taking the placebo required prostate surgery, compared to 5% of men taking finasteride. An inability to urinate developed in 7% of men taking the placebo and 3% of men taking the drug. Finasteride therapy caused the prostate to shrink and increased the flow of urine.

Published
1998

Catalog

Books, media, physical & digital resources
See catalog results